SG11201705694VA - Chlorophyll composition - Google Patents

Chlorophyll composition

Info

Publication number
SG11201705694VA
SG11201705694VA SG11201705694VA SG11201705694VA SG11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA
Authority
SG
Singapore
Prior art keywords
chlorophyll composition
chlorophyll
composition
Prior art date
Application number
SG11201705694VA
Other languages
English (en)
Inventor
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Original Assignee
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chitra Vasant Savangikar, Vasant Anantrao Savangikar filed Critical Chitra Vasant Savangikar
Publication of SG11201705694VA publication Critical patent/SG11201705694VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201705694VA 2015-01-19 2016-01-15 Chlorophyll composition SG11201705694VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN178MU2015 2015-01-19
PCT/IN2016/050017 WO2016116950A2 (en) 2015-01-19 2016-01-15 Chlorophyll composition

Publications (1)

Publication Number Publication Date
SG11201705694VA true SG11201705694VA (en) 2017-08-30

Family

ID=56417899

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705694VA SG11201705694VA (en) 2015-01-19 2016-01-15 Chlorophyll composition

Country Status (10)

Country Link
US (2) US12194052B2 (enrdf_load_stackoverflow)
EP (1) EP3247323B1 (enrdf_load_stackoverflow)
JP (3) JP6772151B2 (enrdf_load_stackoverflow)
CN (2) CN107427417A (enrdf_load_stackoverflow)
AU (1) AU2016210540B2 (enrdf_load_stackoverflow)
BR (1) BR112017015338A2 (enrdf_load_stackoverflow)
EA (1) EA201791319A1 (enrdf_load_stackoverflow)
ES (1) ES2879996T3 (enrdf_load_stackoverflow)
SG (1) SG11201705694VA (enrdf_load_stackoverflow)
WO (1) WO2016116950A2 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107427417A (zh) * 2015-01-19 2017-12-01 C·V·萨万基卡尔 叶绿素组合物
EP4059493A1 (en) * 2021-03-16 2022-09-21 The Secretary, Department Of Atomic Energy A chlorophyllin containing pharmaceutical composition for prevention of pathogenesis of coronavirus disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729586A (en) 1952-02-01 1956-01-03 Rystan Company Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids
BE516996A (enrdf_load_stackoverflow) 1952-02-19
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
DE4033530A1 (de) * 1990-10-22 1992-04-23 Univ Schiller Jena Kristallisationsinhibitor
JPH04327534A (ja) * 1991-04-24 1992-11-17 Mitsuo Namiki 活性酸素による障害の予防及び治療剤
JPH04356420A (ja) * 1991-05-31 1992-12-10 Nisshin Flour Milling Co Ltd チアミン・コバルト・クロロフィリン錯化合物含有組成物
CN1078468C (zh) 1998-07-02 2002-01-30 许德余 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途
JP3657203B2 (ja) 2000-04-21 2005-06-08 エーザイ株式会社 銅クロロフィリン塩含有液剤組成物
JP2003081741A (ja) * 2001-09-13 2003-03-19 Nikko Seiyaku Kk 皮膚外用剤
JP4068442B2 (ja) * 2001-12-03 2008-03-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 味覚改善組成物
CN101111254B (zh) * 2005-01-31 2012-05-09 同和药品株式会社 用于预防和治疗肾病的药物组合物以及含有草药提取物的保健食品
US7887848B2 (en) * 2006-05-31 2011-02-15 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
US7947827B2 (en) * 2006-06-30 2011-05-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
US20080317725A1 (en) * 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物
CN102462671A (zh) 2010-11-18 2012-05-23 何国增 叶绿素铜钠胶囊的制备方法
CN102138919A (zh) 2011-01-28 2011-08-03 武汉联合药业有限责任公司 铁叶绿酸钠用于促进红细胞生成的新用途
CN103027873A (zh) * 2011-10-10 2013-04-10 马美琳 一种消炎止血牙膏
CN103285097B (zh) 2012-02-22 2014-12-10 西安世纪盛康药业有限公司 肾康注射液在制备防治放疗或化疗所致肾毒性药物中的应用
CA2897448A1 (en) 2013-01-08 2014-07-17 Jerome Schentag Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
CN107427417A (zh) * 2015-01-19 2017-12-01 C·V·萨万基卡尔 叶绿素组合物

Also Published As

Publication number Publication date
WO2016116950A3 (en) 2016-10-13
AU2016210540B2 (en) 2018-10-11
CN117100756A (zh) 2023-11-24
EP3247323A2 (en) 2017-11-29
US12194052B2 (en) 2025-01-14
EA201791319A1 (ru) 2018-01-31
CN107427417A (zh) 2017-12-01
JP2021006555A (ja) 2021-01-21
WO2016116950A4 (en) 2016-12-01
EP3247323A4 (en) 2018-07-11
AU2016210540A1 (en) 2017-08-10
JP2025066799A (ja) 2025-04-23
US20250090546A1 (en) 2025-03-20
WO2016116950A2 (en) 2016-07-28
JP2018502893A (ja) 2018-02-01
ES2879996T3 (es) 2021-11-23
BR112017015338A2 (pt) 2018-01-09
US20180325915A1 (en) 2018-11-15
JP6772151B2 (ja) 2020-10-21
EP3247323B1 (en) 2021-03-03

Similar Documents

Publication Publication Date Title
GB201512030D0 (en) Composition
GB201505527D0 (en) Composition
GB201521507D0 (en) Composition
GB201506827D0 (en) Composition
GB201506825D0 (en) Composition
GB201506830D0 (en) Composition
PL3344702T3 (pl) Kompozycja
GB201506829D0 (en) Composition
GB201504665D0 (en) Composition
GB2545773B (en) Composition
GB201522603D0 (en) Composition
GB201515639D0 (en) Composition
GB201522681D0 (en) Composition
GB201519327D0 (en) Composition
GB201518348D0 (en) Composition
GB201514585D0 (en) Composition
GB201506828D0 (en) Composition
GB201505520D0 (en) Composition
GB201504307D0 (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
SG11201705694VA (en) Chlorophyll composition
GB201521384D0 (en) Composition
GB2537648B (en) Composition
GB201515734D0 (en) Composition